Radiotherapy (RT) is standard-of-care in cancer management; however, RT efficacy remains limited. Here, the authors test whether membrane camouflaged BCG bacteria (MBCG) enhance response to RT in preclinical models of glioblastoma. MBCG efficiently targets tumor tissues, induces trained immunity in tumor-associated macrophages, and enhances the RT-induced anti-tumor responses.
- Ke Ren
- Ziyang Yuan
- Haishi Qiao